Acute promyelocytic leukemia after whole brain irradiation of primary brain lymphomainan HIV-infected patient

European Journal of Medical Research

J Begovac¹  M Lisic¹  R Civljak¹  T Maretic¹  K Dubravcic²  R Zadro²  I Radman³  A Boban³ 

[1] University Hospital for Infectious Diseases, Zagreb, Croatia;Clinical Institute of Laboratory Diagnostics, Clinical Hospital Center Zagreb, Zagreb, Croatia;Division of Hematology, Department of Internal Medicine, Clinical Hospital Center Zagreb, Zagreb, Croatia

关键词: primary central nervous system lymphoma;    acute promyelocytic leukemia;    HIV;   

Others  :  1094050
DOI  :  10.1186/2047-783X-14-1-42

 received in 2008-09-14, accepted in 2008-12-03,  发布年份 2009

【 摘 要 】

The occurrence of acute promyelocytic leukemia (APL) in HIV-infected patients has been reported in only five cases. Due to a very small number of reported HIV/APL patients who have been treated with different therapies with the variable outcome, the prognosis of APL in the setting of the HIV-infection is unclear. Here, we report a case of an HIV-patient who developed APL and upon treatment entered a complete remission. A 25-years old male patient was diagnosed with HIV-infection in 1996, but remained untreated. In 2004, the patient was diagnosed with primary central nervous system lymphoma. We treated the patient with antiretroviral therapy and whole-brain irradiation, resulting in complete remission of the lymphoma. In 2006, prompted by a sudden neutropenia, we carried out a set of diagnostic procedures, revealing APL. Induction therapy consisted of standard treatment with all-trans-retinoic-acid (ATRA) and idarubicin. Subsequent cytological and molecular analysis of bone marrow demonstrated complete hematological and molecular remission. Due to the poor general condition, consolidation treatment with ATRA was given in March and April 2007. The last follow-up 14 months later, showed sustained molecular APL remission. In conclusion, we demonstrated that a complete molecular APL remission in an HIV-patient was achieved by using reduced-intensity treatment.

【 授权许可】

   
2009 I. Holzapfel Publishers

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Sutton L, Guénel P, Tanguy ML, Rio B, Dhedin N, Casassus P, Lortholary O: French Study Group on Acute Myeloid Leukaemia in HIV-Infected Patients. Acute myeloid leukaemia in human immunodeficiency virus-infected adults: epidemiology, treatment feasibility and outcome. Br J Haematol 2001, 112(4):900-908.
• [2]De Vita S, De Matteis S, Laurenti L, Sorà F, Tarnani M, Cingolani A, Sica S: Acute promyelocytic leukemia in an HIV-infected patient: a case report. Am J Hematol 2006, 81(4):300.
• [3]Kudva GC, Maliekel K, Richart JM, Batanian JR, Grosso LE, Sokol-Anderson M, Petruska PJ: Acute promyelocytic leukemia and HIV-1 infection: case report and review of the literature. Am J Hematol 2004, 77(3):287-290.
• [4]Calvo R, Ribera JM, Battle M, Sancho JM, Granada I, Flores A, Millá F, Feliu E: Acute promyelocytic leukemia in a HIV seropositive patient. Leuk Lymphoma 1997, 26(5-6):621-624.
• [5]Beaumont M, Sanz M, Carli PM, Maloisel F, Thomas X, Detourmignies L, Guerci A, Gratecos N, Rayon C, San Miguel J, Odriozola J, Cahn JY, Huguet F, Vekhof A, Stamatoulas A, Dombret H, Capote F, Esteve J, Stoppa AM, Fenaux P: Therapy-related acute promyelocytic leukemia. J Clin Oncol 2003, 21(11):2123-2137.
• [6]Maeda Y, Yamaguchi T, Hijikata Y, Morita Y, Tanaka M, Hirase C, Takai S, Tatsumi Y, Kanamaru A: All-trans retinoic acid attacks reverse transcriptase resulting in inhibition of HIV-1 replication. Hematology 2007, 12(3):263-266.